No retraction, correction or concern found when last checked on Oct 30, 2026.
Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review
Raj Kumar Singh, Kuldeep Dhama, Sandip Chakraborty and 11 more
Veterinary Quarterly · 2019 · Review · CC BY
doi:10.1080/01652176.2019.1580827
Abstract
Nipah (Nee-pa) viral disease is a zoonotic infection caused by Nipah virus (NiV), a paramyxovirus belonging to the genus Henipavirus of the family Paramyxoviridae. It is a biosafety level-4 pathogen, which is transmitted by specific types of fruit bats, mainly Pteropus spp. which are natural reservoir host. The disease was reported for the first time from the Kampung Sungai Nipah village of Malaysia in 1998. Human-to-human transmission also occurs. Outbreaks have been reported also from other countries in South and Southeast Asia. Phylogenetic analysis affirmed the circulation of two major clades of NiV as based on currently available complete N and G gene sequences. NiV isolates from Malaysia and Cambodia clustered together in NiV-MY clade, whereas isolates from Bangladesh and India clusterered within NiV-BD clade. NiV isolates from Thailand harboured mixed population of sequences. In humans, the virus is responsible for causing rapidly progressing severe illness which might be characterized by severe respiratory illness and/or deadly encephalitis. In pigs below six months of age, respiratory illness along with nervous symptoms may develop. Different types of enzyme-linked immunosorbent assays along with molecular methods based on polymerase chain reaction have been developed for diagnostic purposes. Due to the expensive nature of the antibody drugs, identification of broad-spectrum antivirals is essential along with focusing on small interfering RNAs (siRNAs). High pathogenicity of NiV in humans, and lack of vaccines or therapeutics to counter this disease have attracted attention of researchers worldwide for developing effective NiV vaccine and treatment regimens.
References 267
- 1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/b978-0-444-53488-0.00032-8
- 2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.3201/eid1012.040452
- 3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.virusres.2013.08.002
- 4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jcm.01875-17
- 5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.apjtm.2016.05.012
- 6.
- 7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1111/pbi.12460
- 9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1093/infdis/jiy612
- 10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/82_2012_209
- 11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1080/13550280500187435
- 12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1177/1010539510370908
- 13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1146/annurev-animal-030117-014628
- 14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.4269/ajtmh.2009.80.96
- 15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.79.11.6690-6702.2005
- 16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1586/14787210.4.1.43
- 17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.jviromet.2007.01.003
- 18.
- 19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.meegid.2018.01.007
- 20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.20506/rst.36.2.2687
- 21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1371/journal.pone.0061316
- 22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1007/82_2012_213
- 23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.antiviral.2013.06.012
- 24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.vaccine.2016.03.075
- 25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 27.
- 28.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1099/0022-1317-82-9-2151
- 30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.13040/ijpsr.0975-8232.9(8).3128-35
- 31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1186/1743-422x-3-47
- 32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s0140-6736(18)31252-2
- 33.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1128/jvi.01852-10
- 34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.4103/jfmpc.jfmpc_137_18
- 35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/j.jviromet.2006.05.003
- 36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1186/1743-422x-7-115
- 37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 38.
- 39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s0140-6736(99)04299-3
- 40.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library10.1016/s1386-6532(02)00268-8
Cited by papers we hold 4
- Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies · 2022Not checked
- Henipaviruses-A constant threat to livestock and humans. · 2022Not checked
- COVID-19: animals, veterinary and zoonotic links · 2020No notice
- Analysis of Nipah Virus Codon Usage and Adaptation to Hosts · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.